Jimmy Ruisheng

Jimmy Ruisheng

New type of medicine that is based on personalized medicine and is developing rapidly with the advancement of genomic sequencing technology and the cross-application of bioinformatics and big data science.

Market cap
-
Enterprise valuation
AUD85—128m (Dealroom.co estimates Mar 2022.)
Suzhou Shi Jiangsu (HQ)

  • Edit

Recent News about Jimmy Ruisheng

Edit